FDA Pilot Project to Track and Trace Pharmaceutical Drugs in the Supply Chain


The FDA is launching a pilot program that will ensure greater accountability of the pharmaceutical drug supply chain in the United States.

According to European pharmaceutical journal, the pilot will test innovative and emerging approaches to improve prescription drug tracing and verification in the United States. It also aims to reduce the diversion of drugs distributed domestically, in hopes of preventing counterfeit drugs from entering the supply chain.

“As part of our ongoing efforts to protect our country’s drug supply, today we are giving industry the opportunity to test new technologies that can help strengthen the accountability of drug chain participants. supply and improve our ability to trace prescription drugs at every step in the distribution chain,” FDA Commissioner Scott Gottlieb said in a statement. “We recognize that product tracking and tracing is critical to industry’s ability to detect and eliminate potentially harmful drugs from the drug supply chain. This pilot project is one of many steps we are taking to foster innovative ways to improve drug supply security.

In addition to drug tracing, the program also aims to assist the FDA and members of the pharmaceutical distribution supply chain in the development of the interoperable electronic system that will be in place by 2023.


Comments are closed.